Anavex Life Sciences
(NASDAQ) AVXL
Anavex Life Sciences Financials at a Glance
Market Cap
$266.89M
Revenue (TTM)
$0.00
Net Income (TTM)
$39.95M
EPS (TTM)
$-0.46
P/E Ratio
-6.19
Dividend
$0.00
Beta (Volatility)
1.73 (High)
Dividend
$0.00
Beta (Volatility)
1.73 (High)
Price
$2.81
Volume
83,041
Open
$2.85
Price
$2.81
Volume
83,041
Open
$2.85
Previous Close
$2.81
Daily Range
$2.75 - $2.89
52-Week Range
$2.61 - $13.99
Dividend
$0.00
Beta (Volatility)
1.73 (High)
Price
$2.81
Volume
83,041
Open
$2.85
Previous Close
$2.81
Daily Range
$2.75 - $2.89
52-Week Range
$2.61 - $13.99
AVXL News
Is Anavex Life Sciences a Buy?
AVXL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Anavex Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
34
CEO
Christopher U. Missling, PhD, MBA
Website
www.anavex.comHeadquarters
New York City, NY 10019, US
AVXL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-34%
Return on Capital
-35%
Return on Assets
-30%
Earnings Yield
-16.16%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$266.89M
Shares Outstanding
92.67M
Volume
83.04K
Short Interest
0.00%
Avg. Volume
1.64M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$51.41M
EBITDA
$46.38M
Operating Cash Flow
$39.04M
Capital Expenditure
$0.00
Free Cash Flow
$39.04M
Cash & ST Invst.
$102.58M
Total Debt
$0.00
Anavex Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$266.89M
N/A
Market Cap/Employee
$6.35M
N/A
Employees
42
N/A
Net Income
$5.68M
+53.1%
EBITDA
$6.78M
+50.1%
Quarterly Fundamentals
Net Cash
$131.75M
+9.1%
Accounts Receivable
$844.00K
-67.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-30.04%
N/A
Return on Invested Capital
-35.22%
N/A
Free Cash Flow
$7.15M
+41.0%
Operating Cash Flow
$7.15M
+41.0%